AI Agent Automation Platforms
How can we cut our specialty drug referral backlog when intake is mostly faxes and PDFs?
11 min read
Most specialty-drug teams don’t have a “referral problem.” They have a fax and PDF problem.
Referrals arrive in every format imaginable. Staff spend 10–20 minutes per referral hunting through pages, re-keying into the EHR, checking portals, and chasing missing details. By the time everything is entered and benefits are verified, you’re sitting on a multi-day backlog, frustrated prescribers, and delayed starts.
You don’t clear that backlog with one more spreadsheet or “intake widget.” You clear it by changing who does the work: shifting repetitive intake and verification tasks from humans to AI agents that operate like a back-office team—across fax, PDFs, portals, and phone.
Below is a ranked breakdown of your best options if your intake is mostly faxes and PDFs and you need the backlog gone, not just “better managed.”
Quick Answer: The best overall choice for cutting a specialty-drug referral backlog built on faxes and PDFs is deploying AI intake agents that read, interpret, and act on referrals end-to-end. If your priority is incremental improvement without new technology, tightening triage, batching, and queue discipline is often a stronger fit. For organizations constrained by internal IT, compliance, or budget cycles, consider a phased rollout starting with one high-volume drug or site.
At-a-Glance Comparison
| Rank | Option | Best For | Primary Strength | Watch Out For |
|---|---|---|---|---|
| 1 | AI intake agents (like Mandolin) | Teams drowning in fax/PDF referrals that need backlog to zero and faster starts | End-to-end automation across fax, PDFs, portals, and phone with logged, traceable actions | Requires change management and clear guardrails for scope & oversight |
| 2 | Operational triage, batching, and queue redesign | Teams needing improvement now while larger tech decisions are pending | Uses existing staff and tools; clarifies “what gets done first” | Relieves pressure but rarely eliminates backlogs or staffing constraints |
| 3 | Phased, narrow-scope automation rollout | Teams with IT/compliance constraints or skeptical stakeholders | Builds proof with one workflow (e.g., a single drug or payer) before scaling | If scoped too narrowly, benefits may look marginal and lose momentum |
Comparison Criteria
We evaluated each approach using criteria operators actually feel in their day-to-day:
- Backlog impact: How much does this option reduce your fax-to-EHR delay and number of referrals waiting in the queue? The benchmark: moving from multi-day lag to real-time or same-day processing.
- Time-to-therapy & denials risk: How does it affect time from referral receipt to ready-to-treat, and the likelihood of missing information or policy misalignment turning into denials or restarts?
- Staffing & scalability: What happens when volume spikes or a new drug launches? Does the approach scale with demand without adding FTEs, outsourcing, or overtime?
Detailed Breakdown
1. AI intake agents (Best overall for eliminating fax/PDF backlogs)
AI intake agents that act like trained back-office specialists are the top choice because they directly attack the real bottleneck: the manual work of reading, interpreting, and acting on fax/PDF referrals and then pushing that work all the way through portals, fax, and phone.
Platforms like Mandolin are built specifically for this messy middle.
What it does well:
-
Turns faxes and PDFs into structured, EHR-ready data in minutes
AI agents read referral forms, lab reports, and clinical notes regardless of formatting or source and enter the right details into your EHR.- One national AIC was processing ~250 documents/day, at ~20 minutes each, with up to 3 days before anything hit the EHR. With Mandolin’s agents, that same workflow dropped to ~3 minutes per document and an end-to-end turnaround under 2 hours—a 24x speed improvement.
- That kind of step-function improvement is how you move from “4-day backlog” to zero-day backlog and real-time processing.
-
Executes the next steps—not just data capture
The real drain on your staff isn’t just reading the fax—it’s everything that comes after:- Logging into payer portals to run benefits
- Checking eligibility and coverage specifics
- Matching to medical policy and documenting criteria
- Flagging missing labs or notes, and initiating outreach
- Starting prior auth packages and routing for provider review
AI intake agents handle these steps across the same channels your team uses today: portals, fax, and phone. Every action is logged and traceable, which matters when you’re working under HIPAA, BAAs, and payer audit risk.
-
Scales without adding headcount or outsourcing
When volume doubles or a new therapy launches, the usual answer is overtime or another vendor. AI intake agents change that math:- One national AIC scaled to 4,500+ patients/month while refocusing 13 outsourced FTEs from repetitive tasks to complex cases.
- Another eliminated a 4-day prescription backlog that had required 2–3 FTEs just to tread water. With intake automated, prescriptions are processed in real time.
-
Improves both economics and patient access
Faster intake isn’t just an operational win—it pulls down your entire time-to-therapy curve. When the referral is in the EHR within hours, with a completed benefits investigation and clean documentation, your clinical and scheduling teams can move.- Patients start therapy sooner.
- You avoid denials tied to missing labs, incomplete documentation, or incorrect policy interpretation.
- Finance sees more predictable revenue, with less leakage from avoidable write-offs.
Tradeoffs & limitations:
-
Requires clear scope and governance
AI agents should handle administrative workflow, not clinical judgment. That means:- Defining which tasks are fully automated (e.g., data entry, portal checks) vs. which require human sign-off (e.g., final clinical criteria review).
- Putting audit trails in place so every action is timestamped and attributable. Mandolin’s model explicitly leans into “Fully Compliant, Always Transparent” with logged agent actions.
-
Change management still matters
Even if there are no APIs or heavy integrations—Mandolin, for instance, works directly in your existing systems—the operation still needs:- Updated SOPs
- Clear escalation paths when agents flag exceptions
- Training for staff to move from “do the work” to “review and manage the work”
Decision Trigger: Choose AI intake agents if your backlog is measured in days, your intake is mostly faxes/PDFs, and you want to get to real-time or same-day processing without adding staff. This is the best fit when leadership is ready to measure success in minutes-per-document, backlog days, and denials avoided—not just “we implemented a new tool.”
2. Operational triage, batching, and queue redesign (Best for teams needing immediate, no-new-tech relief)
Refining your intake operations—without changing your tech stack—can absolutely cut some of your backlog. This option ranks second because it improves throughput and predictability, but it can’t fully overcome the structural limits of manual fax/PDF work.
What it does well:
-
Clarifies what gets done first (and what waits)
Many backlogs are actually prioritization problems: everything is “stat” so nothing is. Tightening triage can help:- Create clear priority tiers (e.g., first-dose initiations, therapy restarts to avoid gaps, time-sensitive biologics, routine refills).
- Route high-priority referrals to your fastest, most experienced staff.
- Set explicit SLAs: e.g., new starts triaged within 2 hours of fax receipt, refills within 24 hours.
-
Reduces context-switching with batching
Staff lose time toggling between payers, drugs, and referral types. Batching similar work—“all new starts for Drug X,” “all Blue Cross portal work”—can shave minutes per referral:- Standardize checklists for each drug/payer combo so staff aren’t re-thinking the process every time.
- Use simple queues or worklists sorted by payer or drug to cluster tasks.
-
Makes throughput and backlogs more visible
Even basic dashboards (Excel + shared trackers) let you:- See how many referrals are in each stage (faxed, triaged, benefits complete, PA submitted).
- Identify bottlenecks (e.g., one portal that always slows things down).
- Forecast staffing needs for seasonal peaks or new drug launches.
Tradeoffs & limitations:
-
Ceilinged by human capacity
Cleaning up triage and batching can take you from 12 minutes per referral to 9–10. It won’t take you from 12 minutes to 3 minutes—and it certainly won’t eliminate multi-day backlogs if volume keeps rising.- When one national AIC made their processes as tight as possible, they still needed 100+ FTEs to push ~250 documents/day with 3-day lag. The capacity ceiling is real.
-
Doesn’t fix the messy middle
Your team is still logging into portals one-by-one, interpreting PDFs, and chasing missing info via phone and fax. Every new payer rule, benefit design, or medical policy tweak adds complexity your staff must manually absorb.
Decision Trigger: Lean into triage and queue redesign if you need relief in the next 2–4 weeks, leadership isn’t ready to move on AI, or IT/compliance approvals are months away. Treat it as necessary—but not sufficient—if your goal is a zero-day backlog and scalable growth.
3. Phased, narrow-scope automation rollout (Best for constrained or skeptical environments)
A phased rollout—starting with one high-volume drug, one site, or one payer—can be the right move when you know you need automation but operate in a conservative environment. It ranks third because, while it de-risks adoption, it can underwhelm if scoped too narrowly.
What it does well:
-
Builds proof without overhauling everything at once
You can start where pain is concentrated and measurement is clean:- Example: Automate intake + benefits verification for a single high-volume biologic.
- Track: minutes per referral, time from fax receipt to EHR entry, backlog days, and denials linked to missing info.
- Use that pilot to show concrete before/after: “We moved from 10–12 minutes per Rx and a 4-day backlog to same-day processing with zero backlog.”
-
Eases IT, compliance, and stakeholder concerns
Starting with one workflow makes it easier to:- Run a focused security and HIPAA review, including how PHI is handled, logged, and stored.
- Demonstrate that AI agents operate within defined guardrails and don’t touch clinical decisions.
- Get buy-in from skeptical physicians and operations leaders who want to “see it work here.”
-
Creates a template you can replicate
Once one drug/payer/site is live, you can clone the model:- Copy the intake SOPs, QA checks, and escalation paths.
- Apply the same measurement framework to the next cohort.
- Build a portfolio of internal case studies that show impact on time-to-therapy, denials, and staffing.
Tradeoffs & limitations:
-
If you go too narrow, the win looks small
Automating one niche drug that only sees 10 referrals a week won’t move your backlog metrics enough to convince skeptics.- Choose a high-volume, representative workflow so improvements are visible in your global numbers.
- Set expectations: the goal of phase one is to prove the model, not to solve every backlog issue overnight.
-
Risk of “pilot purgatory”
Without a clear path from phase one → phase two → system-wide deployment, pilots can stall—even when they work. You need a roadmap upfront:- “If we see X% reduction in minutes per document and backlog days on this cohort, we expand to Y and Z cohorts in Q3.”
Decision Trigger: Use a phased rollout if your organization needs to see proof inside your own workflows before scaling, or if IT/compliance demand a tightly scoped initial deployment. Make sure the pilot is big enough and well-measured enough to justify expansion.
How to Decide What to Do Next
If your intake is mostly faxes and PDFs, your backlog isn’t a scheduling issue—it’s a labor model issue. You have three practical levers:
-
Change who does the work
- AI intake agents (like Mandolin’s) take the repetitive, portal- and fax-based steps off your staff’s plate. This is what drives 24x speed, under-2-hour turnaround, and zero-day backlogs without adding FTEs.
-
Change how work is prioritized and batched
- Operational triage and queue redesign can buy you breathing room and reduce noise, but won’t fundamentally shift the minutes-per-referral math.
-
Change the scope and pace of adoption
- A phased rollout lets you prove value in one workflow before scaling, which is often the difference between a good idea and an approved budget.
If your backlog is already measured in days, and volume is growing, incremental tweaks won’t be enough. The most durable path is to put AI agents in the back office doing the intake work for you—reading faxes, navigating portals, making calls, and updating the EHR—while your team focuses on exceptions and patient-facing work.
Final Verdict
- Best overall: End-to-end AI intake agents are the decisive move for organizations that want to cut backlog to zero, compress fax-to-EHR time from days to hours, and scale without adding staff or outsourcing.
- Best “no new tech” option: Tighter triage, batching, and queue discipline can reduce pain and buy time, but will eventually hit the ceiling of human capacity.
- Best path in conservative environments: A phased rollout focused on one high-volume workflow proves value, addresses compliance concerns, and builds the internal case to expand automation across your specialty-drug operations.
If your reality is a stack of faxed referrals, overworked staff, and delayed starts, it’s time to let AI agents handle the messy middle—so your team can stop fighting the backlog and start focusing on patients.